K. Shimoda et al., PLASMA-CONCENTRATIONS OF TIMIPERONE AND ITS REDUCED METABOLITE IN THEPATIENTS ON TIMIPERONE, Psychiatry and clinical neurosciences ( Psychiatry and clinical neurosciences (Carlton. Print)), 52(5), 1998, pp. 535-540
Plasma levels of timiperone (TIM) and reduced timiperone (RTIM) were d
etermined in 10 schizophrenic patients who were treated with TIM. Acti
vities of ketone reductase in red blood cells (RBC) were assayed using
TIM and haloperidol (HAL) as substrates. Plasma levels of TIM and RTI
M ranged from 3.2 ng/mL to 9.5 ng/mL and from 1.7 ng/mL to 7.6 ng/mL,
respectively, and similar to four-fold inter-individual variations in
RTIM/TIM (0.37-1.43, 0.67 +/- 0.25) were observed. There were signific
ant and positive correlations between plasma levels of TIM or RTIM wit
h the daily doses of TIM (mg/kg body weight); TIM (ng/mL) = 19.5 x dai
ly dose of TIM (mg/kg) + 1.3, r = 0.79, n = 18, P < 0.01; RTIM (ng/mL)
= 13.1 x daily dose of TIM (mg/kg) + 0.7, r = 0.73, n = 18, P < 0.001
). Given 0.3 mg/kg of TIM, a plasma level of TIM as 7.15 ng/mL was pre
dicted, which is similar to 60% that of HAL. The activity of TIM reduc
tase in RBC was determined as similar to 70% of HAL reductase in RBC,
although the correlation between the activities of TIM reductase and H
AL reductase in RBC was high (r = 0.98, n = 10, P < 0.001).